U.S. drug development phase I to approval success rates 2011-2020 by disease area
This statistic shows the likelihood of approval from Phase I for new drugs in the U.S., within the period from January 1, 2011, to November 30, 2020, by disease area. It was found that the likelihood of approval from Phase I of drug development was highest for drugs in hematology.